X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1577) 1577
Publication (97) 97
Book Review (44) 44
Newsletter (26) 26
Book Chapter (9) 9
Newspaper Article (4) 4
Conference Proceeding (2) 2
Book / eBook (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
levetiracetam (1461) 1461
humans (1049) 1049
epilepsy (950) 950
clinical neurology (898) 898
index medicus (886) 886
piracetam - analogs & derivatives (742) 742
female (696) 696
male (696) 696
anticonvulsants - therapeutic use (694) 694
seizures (595) 595
anticonvulsants - adverse effects (497) 497
antiepileptic drugs (490) 490
adult (476) 476
piracetam - therapeutic use (465) 465
epilepsy - drug therapy (404) 404
neurology (401) 401
middle aged (389) 389
anticonvulsants (366) 366
piracetam - adverse effects (347) 347
treatment outcome (331) 331
double-blind (319) 319
neurosciences (316) 316
efficacy (287) 287
pharmacology & pharmacy (282) 282
adolescent (281) 281
aged (271) 271
anticonvulsants - administration & dosage (254) 254
children (238) 238
analysis (235) 235
child (234) 234
drug therapy (217) 217
animals (213) 213
psychiatry (212) 212
lamotrigine (209) 209
piracetam - administration & dosage (195) 195
seizures - drug therapy (189) 189
carbamazepine (183) 183
phenytoin (183) 183
tolerability (183) 183
dose-response relationship, drug (181) 181
status epilepticus (179) 179
topiramate (179) 179
pediatrics (173) 173
retrospective studies (171) 171
care and treatment (169) 169
young adult (169) 169
pharmacokinetics (164) 164
drugs (163) 163
drug therapy, combination (151) 151
medicine & public health (149) 149
anticonvulsants - pharmacology (143) 143
epilepsies, partial - drug therapy (131) 131
multicenter (125) 125
therapy (125) 125
antiepileptic drug (124) 124
partial-onset seizures (124) 124
electroencephalography (123) 123
child, preschool (121) 121
refractory partial seizures (120) 120
safety (120) 120
dosage and administration (111) 111
partial seizures (111) 111
behavioral sciences (110) 110
aged, 80 and over (107) 107
anticonvulsants - pharmacokinetics (106) 106
piracetam - pharmacology (106) 106
research (106) 106
monotherapy (105) 105
prospective studies (103) 103
valproate (103) 103
complications and side effects (102) 102
placebo-controlled trial (101) 101
valproic acid (101) 101
follow-up studies (98) 98
add-on therapy (97) 97
health aspects (96) 96
convulsions & seizures (95) 95
double-blind method (94) 94
oxcarbazepine (94) 94
etiracetam (91) 91
rats (91) 91
risk factors (91) 91
management (90) 90
status epilepticus - drug therapy (89) 89
gabapentin (88) 88
trial (87) 87
refractory epilepsy (86) 86
clinical trials (85) 85
drug administration schedule (83) 83
intravenous levetiracetam (82) 82
adults (81) 81
medical research (81) 81
seizure (81) 81
antiepileptic drug levetiracetam (79) 79
brain (78) 78
infant (78) 78
disease models, animal (75) 75
piracetam - pharmacokinetics (75) 75
seizures - etiology (75) 75
zonisamide (74) 74
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1579) 1579
Spanish (13) 13
German (10) 10
Russian (5) 5
French (3) 3
Hungarian (2) 2
Turkish (2) 2
Japanese (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Postgraduate Medical Journal, ISSN 0032-5473, 09/2017, Volume 93, Issue 1103, pp. 566 - 566
Treatment with levetiracetam was associated with a seven-fold increase in the risk of depression. 2 Nonetheless, rapid loading, easy conversion from oral to... 
DOUBLE-BLIND | MEDICINE, GENERAL & INTERNAL | Depression | Brivaracetam | Epilepsy | Levetiracetam | Care and treatment | Dosage and administration | Depression, Mental | Risk factors | Ligands | Mental depression | Patients
Journal Article
Epilepsy Research, ISSN 0920-1211, 02/2019, Volume 150, pp. 58 - 65
There is limited literature on cognitive, behaviour and sleep-related adverse effects of levetiracetam and oxcarbazepine among adult epilepsy patients, except... 
Oxcarbazepine | Cognition | Sleep | Behaviour | Levetiracetam | MONOTHERAPY | NOCTURNAL SLEEP | ADULTS | TOPIRAMATE | CLINICAL NEUROLOGY | PROFILE | PHENYTOIN | QUALITY-OF-LIFE | ANTIEPILEPTIC DRUGS | ASSOCIATION | EXPOSURE | Complications and side effects | Medical research | Anticonvulsants | Epilepsy | Medicine, Experimental
Journal Article
Epilepsy & Behavior, ISSN 1525-5050, 11/2019, Volume 100, p. 106439
The study investigated overall adverse event (AE) burden and specifically psychiatric and behavioral side effects (PBAEs) in persons with epilepsy (PWE) on... 
Levetiracetam monotherapy | Neuroendocrine markers | Adverse events | Psychiatric and behavioral adverse effects | Conventional antiepileptic drugs | Quality of life
Journal Article
Journal Article
International Journal of Neuroscience, ISSN 0020-7454, 9/2014, Volume 124, Issue 9, pp. 627 - 634
Journal Article
Annals of Pharmacotherapy, ISSN 1060-0280, 7/2018, Volume 52, Issue 7, pp. 645 - 649
Background: Few studies on adult and pediatric patients have shown pyridoxine efficacy as additional therapy for those receiving levetiracetam (LEV) to prevent... 
behavioral adverse effects | pyridoxine | child | levetiracetam | POPULATION | EFFICACY | SAFETY | CLINICAL PHARMACOKINETICS | THERAPY | SEIZURES | PHARMACOLOGY & PHARMACY | EXPERIENCE | ADJUNCTIVE LEVETIRACETAM | EPILEPSY | ANTIEPILEPTIC DRUGS
Journal Article
Cureus, ISSN 2168-8184, 05/2018, Volume 10, Issue 5, p. e2705
Levetiracetam is an anti-epileptic that works at the synapse and binds synapse vesicle protein 2A, thereby controlling the release of neurotransmitters. Its... 
Urine | Medicine | Musculoskeletal system | Electrolytes | Kidneys | Dehydrogenases
Journal Article
Clinical Neuropharmacology, ISSN 0362-5664, 07/2015, Volume 38, Issue 4, pp. 144 - 146
Levetiracetam (LEV) efficacy in the treatment of chorea in Huntington disease, paroxysmal nonkinesigenic dyskinesia, paroxysmal kinesigenic choreoathetosis,... 
chorea | dyskinesia | Sydenham chorea | child | levetiracetam | PAROXYSMAL NONKINESIGENIC DYSKINESIA | DISEASE | CHOREOATHETOSIS | PHARMACOLOGY & PHARMACY | CLINICAL NEUROLOGY | Follow-Up Studies | Piracetam - therapeutic use | Chorea - drug therapy | Humans | Piracetam - analogs & derivatives | Nootropic Agents - therapeutic use | Male | Child
Journal Article
Nature Reviews Neurology, ISSN 1759-4758, 10/2012, Volume 8, Issue 10, pp. 532 - 532
Journal Article
Epilepsy and Behavior, ISSN 1525-5050, 2017, Volume 71, Issue Pt A, pp. 73 - 78
Abstract Psychiatric comorbidities are common in people with epilepsy. A retrospective study of characteristics associated with withdrawal due to psychiatric... 
Neurology | Antiepileptic drug | Side effects | Prospective audit | Epilepsy | Psychiatric | Seizures | DEPRESSION | POPULATION | REFRACTORY EPILEPSY | MENTAL-RETARDATION | PSYCHIATRY | CLINICAL NEUROLOGY | INTELLECTUAL DISABILITY | JUVENILE MYOCLONIC EPILEPSY | BEHAVIORAL SCIENCES | PEOPLE | ANXIETY DISORDERS | FOCAL EPILEPSY | LEVETIRACETAM | Pregabalin - adverse effects | Prospective Studies | Pregabalin - therapeutic use | Humans | Medical Audit - methods | Middle Aged | Piracetam - adverse effects | Seizures - drug therapy | Male | Young Adult | Anticonvulsants - adverse effects | Acetamides - therapeutic use | Piracetam - therapeutic use | Sodium Channel Blockers - adverse effects | Acetamides - adverse effects | Aged, 80 and over | Sodium Channel Blockers - therapeutic use | Adult | Female | Retrospective Studies | Mental Disorders - diagnosis | Epilepsy - psychology | Fructose - adverse effects | Mental Disorders - chemically induced | Dibenzazepines | Anticonvulsants - therapeutic use | Pyridones | Fructose - therapeutic use | Epilepsy - diagnosis | Mental Disorders - psychology | Fructose - analogs & derivatives | Piracetam - analogs & derivatives | Adolescent | Epilepsy - drug therapy | Aged | Drug-Related Side Effects and Adverse Reactions - diagnosis | Drug-Related Side Effects and Adverse Reactions - psychology | Seizures - psychology | Drugs | Complications and side effects | Anticonvulsants | Comorbidity | Learning disabilities | Seizures (Medicine) | Mental illness | Depression, Mental
Journal Article
Neurology, ISSN 0028-3878, 04/2004, Volume 62, Issue 8, pp. 1261 - 1273
Journal Article
Journal of Biochemical and Molecular Toxicology, ISSN 1095-6670, 06/2017, Volume 31, Issue 6, p. n/a
Serum paraoxonase (PON1) is a key enzyme related to high‐density lipoprotein (HDL)‐cholesterol particle. It can prevent the oxidation of low‐density... 
paraoxonase | enzyme purification | antiepileptic drug, enzyme inhibition | OXIDATIVE STRESS | PROTEIN | antiepileptic drug | HUMAN PLASMA | BIOCHEMISTRY & MOLECULAR BIOLOGY | LOW-DENSITY-LIPOPROTEIN | ATHEROSCLEROSIS | IN-VITRO | enzyme inhibition | UNKNOWN QUANTITY | TOXICOLOGY | EPILEPSY | ARYLESTERASE ACTIVITY | LEVETIRACETAM | Aryldialkylphosphatase - blood | Humans | Piracetam - adverse effects | Anticonvulsants - pharmacology | Valproic Acid - pharmacology | Anticonvulsants - adverse effects | Aryldialkylphosphatase - antagonists & inhibitors | Piracetam - pharmacology | Primidone - pharmacology | Phenytoin - pharmacology | Amines - adverse effects | Valproic Acid - adverse effects | gamma-Aminobutyric Acid - adverse effects | Enzyme Inhibitors - adverse effects | Primidone - adverse effects | Aryldialkylphosphatase - isolation & purification | Cyclohexanecarboxylic Acids - adverse effects | Enzyme Inhibitors - pharmacology | gamma-Aminobutyric Acid - pharmacology | Aryldialkylphosphatase - metabolism | Turkey | Cyclohexanecarboxylic Acids - pharmacology | Phenytoin - adverse effects | Piracetam - analogs & derivatives | Kinetics | Amines - pharmacology | Enzymes | Anticonvulsants | Chromatography | Drugs | Lipoproteins (low density) | Gabapentin | Paraoxonase | Valproic acid | Antiepileptic agents | Etiracetam | Low density lipoprotein | Cholesterol | Acids | Oxidation | Inhibition | Lipoproteins (high density) | In vitro methods and tests | Phenytoin | Index Medicus
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2017, Volume 40, Issue 11, pp. 1934 - 1940
Journal Article
Neurology, ISSN 0028-3878, 09/2003, Volume 61, Issue 5, pp. 704 - 706
The prevalence and psychopathologic features of psychiatric adverse events (PAE) in 517 patients taking levetiracetam (LEV) were investigated. Fifty-three... 
CLINICAL NEUROLOGY | Prevalence | Humans | Risk Factors | Piracetam - adverse effects | Male | Psychoses, Substance-Induced - epidemiology | Anticonvulsants - adverse effects | Piracetam - analogs & derivatives | Adult | Female | Psychoses, Substance-Induced - diagnosis | Psychoses, Substance-Induced - classification | Levetiracetam
Journal Article
Epilepsy & Behavior, ISSN 1525-5050, 01/2018, Volume 78, pp. 194 - 201
Brivaracetam is a new antiepileptic drug indicated for adjunctive treatment of focal seizures in adults at a dose of 50–200 mg/day taken in two equal doses.... 
Antiepileptic drug | Alprazolam | Subjective measures | Brivaracetam | Abuse potential | Levetiracetam | SAFETY | PSYCHIATRY | CLINICAL NEUROLOGY | PARTIAL-ONSET SEIZURES | LIABILITY ASSESSMENT | CNS PHARMACODYNAMICS | PHARMACOKINETICS | DOUBLE-BLIND | BEHAVIORAL SCIENCES | PLACEBO-CONTROLLED TRIAL | ADJUNCTIVE BRIVARACETAM | ADVERSE EVENT PROFILE | Hypnotics and Sedatives - adverse effects | Central Nervous System Depressants - adverse effects | Humans | Middle Aged | Hypnotics and Sedatives - administration & dosage | Anticonvulsants - administration & dosage | Male | Anticonvulsants - pharmacology | Levetiracetam - adverse effects | Central Nervous System Depressants - pharmacology | Pyrrolidinones - administration & dosage | Young Adult | Anticonvulsants - adverse effects | Alprazolam - administration & dosage | Drug-Related Side Effects and Adverse Reactions | Pyrrolidinones - pharmacology | Adult | Female | Alprazolam - pharmacology | Pyrrolidinones - adverse effects | Double-Blind Method | Alprazolam - adverse effects | Levetiracetam - administration & dosage | Street Drugs - adverse effects | Cross-Over Studies | Euphoria | Adolescent | Central Nervous System Depressants - administration & dosage | Levetiracetam - pharmacology | Hypnotics and Sedatives - pharmacology | Drug abuse | Anticonvulsants | Seizures (Medicine) | Analysis | Central nervous system
Journal Article